NCI (NASDAQ:NCIT) has acquired the outstanding capital stock of CSC’s (NYSE: CSC) AdvanceMed.
AdvanceMed supports services focused on the detection and prevention of fraud, waste, and abuse in healthcare programs, providing investigative services to the Centers for Medicare and Medicaid Services.
NCI purchased the firm for $62 million.